Search Results

Results 111 - 120 of 789 for stem cells. (5.87 seconds)
  • Clue charting cancer gene regulation

    Understanding when and where proteins bind to DNA may be the ticket to identifying cancer at the cellular level, according to researchers at Stanford.

  • Adult stem cells channel early development

    New research from Stanford shows that skeletal stem cells in mice assume a more primitive developmental state in response to extensive regeneration needs and environmental cues.

  • Swimming in polygons to avoid stronger light

    A bioengineering lab has found that Euglena, a microscopic organism that has been studied for hundreds of years, swims in precise polygons when exposed to increased light intensity.

  • Eight researchers awarded NIH grants

    The Stanford scientists will receive $32 million over five years to fund explorations of cancer, the brain, the aging process, chromosomes and the development of cells.

  • Artandi to lead Stanford Cancer Institute

    A cancer biologist, Artandi studies the role of telomerase in stem cells and cancer. He replaces outgoing director Beverly Mitchell.

  • Human skeletal stem cell identified

    Identification of the human skeletal stem cell by Stanford scientists could pave the way for regenerative treatments for bone fractures, arthritis and joint injuries.

  • ‘Discovery Curriculum’ launched

    A redesigned curriculum for Stanford medical students is now being fully implemented. It provides new courses, more flexibility and financial incentives for pursuing long-term research.

  • Toll of armed conflict in Africa

    A Stanford-led analysis of the indirect impact of armed conflict in Africa shows that as many as 3.5 million infants born within 30 miles of combat were killed over two decades.

  • Stunted telomeres found in heart disease

    Patients with cardiomyopathy have abnormally short telomeres in the cells responsible for heart contraction, Stanford researchers find. This disease hallmark opens new pathways for drug discovery.

  • Test predicts lymphoma therapy success

    Changes in circulating tumor DNA levels quickly predict how patients with diffuse large B cell lymphoma are responding to therapy, according to a Stanford-led study. Currently, patients wait months for the results.